NO20031997D0 - CRF-reseptor-antagonist og metoder relatert dertil - Google Patents

CRF-reseptor-antagonist og metoder relatert dertil

Info

Publication number
NO20031997D0
NO20031997D0 NO20031997A NO20031997A NO20031997D0 NO 20031997 D0 NO20031997 D0 NO 20031997D0 NO 20031997 A NO20031997 A NO 20031997A NO 20031997 A NO20031997 A NO 20031997A NO 20031997 D0 NO20031997 D0 NO 20031997D0
Authority
NO
Norway
Prior art keywords
receptor antagonist
methods related
crf receptor
crf
methods
Prior art date
Application number
NO20031997A
Other languages
English (en)
Norwegian (no)
Other versions
NO20031997L (no
Inventor
Mustapha Haddach
Marion C Lanier
Charles Q Huang
James R Mccarthy
Original Assignee
Neurocrine Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurocrine Biosciences Inc filed Critical Neurocrine Biosciences Inc
Publication of NO20031997D0 publication Critical patent/NO20031997D0/no
Publication of NO20031997L publication Critical patent/NO20031997L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/16—Peri-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20031997A 2000-11-03 2003-05-02 CRF-reseptor-antagonist og metoder relatert dertil NO20031997L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US24582100P 2000-11-03 2000-11-03
PCT/US2001/047919 WO2002040480A2 (fr) 2000-11-03 2001-11-02 Antagonistes du recepteur crf et methodes liees a ces derniers

Publications (2)

Publication Number Publication Date
NO20031997D0 true NO20031997D0 (no) 2003-05-02
NO20031997L NO20031997L (no) 2003-05-02

Family

ID=22928212

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20031997A NO20031997L (no) 2000-11-03 2003-05-02 CRF-reseptor-antagonist og metoder relatert dertil

Country Status (11)

Country Link
US (2) US6747034B2 (fr)
EP (1) EP1341793B1 (fr)
JP (1) JP2004529075A (fr)
KR (1) KR20030060927A (fr)
AU (2) AU3958902A (fr)
CA (1) CA2427656A1 (fr)
DE (1) DE60126134T2 (fr)
ES (1) ES2279835T3 (fr)
MX (1) MXPA03003714A (fr)
NO (1) NO20031997L (fr)
WO (1) WO2002040480A2 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7273871B2 (en) * 2001-07-17 2007-09-25 Sb Pharmco Puerto Rico Inc. Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonists
GEP20084540B (en) 2003-01-14 2008-11-25 Arena Pharm Inc 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prpphylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia
CA2527832A1 (fr) * 2003-06-10 2004-12-23 F. Hoffmann-La Roche Ag Derives de 1,3,4-triaza-phenalene et de 1,3,4,6-tetra-azaphenalene
TWI335328B (en) 2003-07-14 2011-01-01 Arena Pharm Inc Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related hereto
US20060024661A1 (en) * 2003-07-30 2006-02-02 The Regents Of The University Of California Modulation of CRF potentiation of NMDA receptor currents via CRF receptor 2
ATE388150T1 (de) * 2003-12-22 2008-03-15 Sb Pharmco Inc Crf-rezeptorantagonisten und diese betreffende verfahren
US7869958B2 (en) * 2004-08-09 2011-01-11 Research Development Foundation Structure-based modulators of B1 G-protein coupled receptors
WO2006081522A2 (fr) * 2005-01-26 2006-08-03 The Regents Of The Unversity Of California Modulation de courants du recepteur nmda au moyen du recepteur de l'orexine et/ou du recepteur du facteur crf
PE20131371A1 (es) 2010-09-22 2013-11-25 Arena Pharm Inc Moduladores del receptor gpr119 y el tratamiento de trastornos relacionados con este
NZ734220A (en) 2015-01-06 2022-01-28 Arena Pharm Inc Methods of treating conditions related to the s1p1 receptor
IL285890B (en) 2015-06-22 2022-07-01 Arena Pharm Inc Slate-free crystal of the arginine salt of (Ar)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-4,3,2,1-tetrahydro-cyclopent[b]indole-3-yl ) acetic acid
US11534424B2 (en) 2017-02-16 2022-12-27 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1129096E (pt) 1998-11-12 2003-09-30 Neurocrine Biosciences Inc Antagonistas de receptor de crf e metodos de tratamento relacionados com os mesmos
DK1129091T3 (da) 1998-11-12 2002-11-04 Neurocrine Biosciences Inc Antagonister for CRF-receptorer og fremgangsmåder med relation dertil

Also Published As

Publication number Publication date
DE60126134T2 (de) 2007-10-18
KR20030060927A (ko) 2003-07-16
MXPA03003714A (es) 2004-05-04
AU3958902A (en) 2002-05-27
ES2279835T3 (es) 2007-09-01
AU2002239589B2 (en) 2005-04-21
WO2002040480A3 (fr) 2003-05-15
EP1341793B1 (fr) 2007-01-17
US20020151557A1 (en) 2002-10-17
NO20031997L (no) 2003-05-02
WO2002040480A2 (fr) 2002-05-23
CA2427656A1 (fr) 2002-05-23
US6747034B2 (en) 2004-06-08
EP1341793A2 (fr) 2003-09-10
US20040266799A1 (en) 2004-12-30
DE60126134D1 (de) 2007-03-08
JP2004529075A (ja) 2004-09-24

Similar Documents

Publication Publication Date Title
IS8526A (is) CRF viðtakamótlyf og aðferðir tengdar þeim
IS7040A (is) 5-HT viðtakabindlar og notkun þeirra
DK1202941T3 (da) Gipssammensætninger og beslægtede fremgangsmåder
DK1122244T3 (da) Uracilforbindelser og anvendelse deraf
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
NO20024874D0 (no) Benzoamidpiperidin-holdige forbindelser og beslektede forbindelser
NO20024355L (no) Nukleosidforbindelser og anvendelser derav
NO20014553D0 (no) Brönnplanlegging og konstruksjon
DK2325317T3 (da) Receptornukleinsyrer og polypeptidr
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
DK1251848T3 (da) Gyraseinhibitorer og anvendelse deraf
NO20032668L (no) Gyraseinhibitorer og anvendelser derav
IS6802A (is) 3-arýlindólafleiður og notkun þeirra sem CB2 viðtakagerandefni
DK1322597T3 (da) Fremgangsmåde og intermediære
NO20030228D0 (no) Antennestruktur og assosiert fremgangsmåte
NO20031997L (no) CRF-reseptor-antagonist og metoder relatert dertil
NO20032542L (no) Dempede anti-CD28-antistoffer og anvendelse derav
DK1334106T3 (da) Imidazolderivater, fremstillingsmetoder deraf og anvendelse deraf
IS7438A (is) Lyfjablanda úr PDE4 eða PDE3/4 tálma og histamínviðtakamótlyfi
NO20030822D0 (no) Nye forbindelser og fremgangsmåter
NO20042500L (no) Chemokin-reseptorantagonister og metoder for anvendelse derav
NO20032821D0 (no) Sea-trosy og beslektede fremgangsmåter
NO20025135D0 (no) Antihypertensive midler og anvendelse
ATE474032T1 (de) Fischer-tropsch-verfahren
ATE320254T1 (de) Crf receptor antagonisten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application